Kick-start appeal – The Institute of Cancer Research, London
Our research has been on hold during the coronavirus crisis, but cancer has not. We need your support today to help us make up for lost time in defeating cancer.
Related Articles
Monthly gift for cancer patients – The Institute of Cancer Research,
At the ICR, we are committed to improving the lives of cancer patients. Yet these discoveries take time and are only possible with continued support…
Scientists identify potential new drug combination for children with
Combining two existing cancer drugs could offer promise for some children with an incurable childhood brain cancer, a new study suggests.
Science Talk – “We don’t know how much time we’ve got left together”
Scientists at The Institute of Cancer Research have helped discover and develop many targeted treatments that are enabling cancer patients to live longer and with…
Science Talk – A new era for treating high-risk neuroblastoma – resea
It’s an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new…
London Marathon – The Institute of Cancer Research, London
Run the London Marathon for the Institute of Cancer Research and raise money for our life-saving research. Sign up today.
Hospital worker to tackle London Marathon in memory of ‘special’ friends
A Watford cancer survivor will take on the London Marathon this weekend in memory of two friends lost to the disease.
Rachel’s London Marathon 2024 fundraiser for The Institute of Cancer Research (ICR)
Help Rachel Talbot raise money to support The Institute of Cancer Research (ICR)
Susan’s 3 marathon challenge Brighton Apr 23 Chicago Oct 23 London Apr 24
Help Susan Farrow raise money to support The Institute of Cancer Research (ICR)
Science Talk – From cancer diagnosis to London Marathon mission – Har
As a fit and healthy former firefighter, Harry Hall didn’t think there was anything to worry about when he developed a lump in his neck.…
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemia
Nature Cancer – Lawson et al. show that genetic inactivation of Phd1 or Phd2 hinders progression of AML and compromises leukemic stem cells. They develop…